Treatment of onychomycosis with oral antifungal agents

Expert Opinion on Drug Delivery

Volumn 2, Issue 3, 2005, Pages 435-440

  Iorizzo, Matilde ^a   Piraccini, Bianca Maria ^a   Rech, Giulia ^a   Tosti, Antonella ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Nail; Onychomycosis; Oral antifungal; Therapy

Indexed keywords

ALPRAZOLAM; ANTACID AGENT; ANTIFUNGAL AGENT; ASTEMIZOLE; BUSPIRONE; BUSULFAN; CARBAMAZEPINE; CIMETIDINE; CISAPRIDE; CYCLOSPORIN; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DIGOXIN; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISONIAZID; ITRACONAZOLE; MIDAZOLAM; PHENYTOIN; PROTON PUMP INHIBITOR; RIFABUTIN; RIFAMPICIN; TERBINAFINE; TERFENADINE; THEOPHYLLINE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; VINCRISTINE; WARFARIN;

ANTIFUNGAL ACTIVITY; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DERMATOPHYTE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG METABOLISM; DYSTROPHY; FINGERNAIL ONYCHOMYCOSIS; FUNGAL COLONIZATION; GASTROINTESTINAL SYMPTOM; HOST SUSCEPTIBILITY; HUMAN; MOULD; MYCOLOGY; NAIL DISEASE; NONHUMAN; ONYCHOMYCOSIS; PANCYTOPENIA; REVIEW; SKIN DISEASE; TASTE DISORDER; TOENAIL ONYCHOMYCOSIS; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; FUNGI; HUMANS; ONYCHOMYCOSIS;

EID: 28044469051     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.3.435     Document Type: Review

References (39)

1. FAERGEMANN J, BARAN R: Epidemiology, clinical presentation and diagnosis of onychomycosis. Br. J. Dermatol. (2003) 149(Suppl. 65):1-4.
2. TOSTI A, PIRACCINI BM, LORENZI S: Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J. Am. Acad. Dermatol. (2000) 42:217-224.
3. KENNA ME, ELEWSKI BE: A US epidemiological survey of superficial fungal diseases. J. Am. Acad. Dermatol. (1996) 35:539-542.
4. HANEKE E: Fungal infections of the nail. Sem. Dermatol. (1991) 10:41-53.
5. MAHONEY JM, BENNET J, OLSEN B: The diagnosis of onychomycosis. Dermatol. Clin. (2003) 21(3):463-467.
6. GEYER AS, ONUMAH N, UYTTENDAELE H, SCHER RK: Modulation of linear nail growth to treat diseases of the nails. J. Am. Acad. Dermatol. (2004) 50:229-234.
7. ZAIAS N, TOSTI A, REBELL G et al.: Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J. Am. Acad. Dermatol. (1996) 34:302-304.
8. ZAIAS N: Onychomycosis. In: The Nail in Health and Disease (2nd Edition). Appleton & Lange, Norwalk, CT USA (1990) 87-105.
9. BARAN R, HAY RJ, TOSTI A, HANEKE E: A new classification of onychomycosis. Br. J. Dermatol. (1998) 139(4):567-571.
10. DANIEL CR III, NORTON LA, SCHER RK: The spectrum of nail disease in patients with human immunodeficiency virus infection. J. Am. Acad. Dermatol. (1992) 27:93-97.
11. GUPTA AK, LYNCH LE: Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence. Cutis (2004) 74(Suppl. 1):10-15.
12. PIRACCINI BM, TOSTI A: White superficial onychomycosis: epidemiological, clinical, and pathological study of 79 patients. Arch. Dermatol. (2004) 140(6):696-701.
13. BARAN R, HAY R, PERRIN C: Superficial white onychomicosis revisited. J. Eur. Acad. Dermatol. Venereol. (2004) 18:569-571.
14. BARAN R: Nail fungal infections and treatment. Hand Clin. (2002) 18(4):625-628.
15. DARKES MJ, SCOTT LJ, GOA KL: Terbinafine: a review of its use in onychomycosis in adults. Am. J. Clin. Dermatol. (2003) 4(1):39-65.
16. TOSTI A, PIRACCINI BM, STINCHI C, et al.: Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J. Am. Acad. Dermatol. (1996) 34(4):595-600.
17. PAVLOTSKY F, ARMONI G, SHEMER A, TRAU H: Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis. J. Dermatol. Treat. (2004) 15:315-320.
18. ZAIAS N, REBELL G: The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Arch. Dermatol. (2004) 140(6):691-695.
19. GUPTA AK, SKINNER AR: Onychomycosis in children: a brief overview with treatment strategies. Pediatr. Dermatol. (2004) 21(1):74-79.
20. GUPTA AK, KATZ HI, SHEAR NH: Drug interactions with itraconazole, fluconazole, and terbinafine and their management. J. Am. Acad. Dermatol. (1999) 41(2 Pt 1):237-249.
21. DEBRUYNE D, COQUEREL A: Pharmacokinetics of antifungal agents in onychomycoses. Clin. Pharmacokinet. (2001) 40(6):441-472.
22. ODOM RB, ALY R, SCHER RK et al.: A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail. J. Am. Acad. Dermatol. (1997) 36(2 Pt 1):231-235.
23. DRAKE L, BABEL D, STEWART DM et al.: Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J. Am. Acad. Dermatol. (1998) 38(6 Pt 2):S87-S94.
24. SCHER RK, BRENEMAN D, RICH P et al.: Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J. Am. Acad. Dermatol. (1998) 38(6 Pt 2):S77-S86.
25. TOSTI A, PIRACCINI BM, IORIZZO M: Management of onychomycosis in children. Dermatol. Clin. (2003) 21(3):507-509.
26. EPSTEIN E: How often does oral treatment of toenail onychomycosis produce a disease free nail? Arch. Dermatol. (1998) 134:1551-1554.
27. GUPTA AK, RYDER JE, JOHNSON AM: Cumulative meta-analysis of systemic antifungals agents for the treatment of onychomycosis. Br. J. Dermatol. (2004) 150:537-544.
28. SCHER RK, BARAN R: Onychomycosis in clinical practice: factors contributing to recurrence. Br. J. Dermatol. (2003) 149(Suppl. 65):5-9.
29. BARAN R, DE DONCKER P: Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals. Acta Derm. Venereol. (1996) 76:82-83.
30. ROBERTS DT, EVANS EG: Subungual dermatophytoma complicating dermatophyte onychomycosis. Br. J. Dermatol. (1998) 138:189-190.
31. GUPTA AK, LYNDE CW, KONNIKOV N: Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J. Am. Acad. Dermatol. (2001) 44(3):485-491.
32. GUPTA AK, KONNIKOV N, LYNDE CW: Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. J. Am. Acad. Dermatol. (2001) 44:479-484.
33. TOSTI A, PIRACCINI BM, LORENZI S, IORIZZO M: Treatment of nondermatophyte mold and Candida onychomycosis. Dermatol. Clin. (2003) 21(3):491-497.
34. GIANNI C, ROMANO C: Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine. Dermatology. (2004) 209:104-110.
35. TOSTI A, PIRACCINI BM, GHETTI E, COLOMBO MD: Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J. Am. Acad. Dermatol. (2002) 47(1):73-76.
36. TOSTI A, PIRACCINI BM: Paronychia. In: Contact Urticaria Syndrome. CRC Press, Boca Raton, NY, USA (1997) 267-278.
37. GUPTA AK, RYDER JE: The use of oral antifungal agents to treat onychomycosis. Dermatol. Clin. (2003) 21(3):469-479.
38. TOSTI A, PIRACCINI BM, STINCHI C, COLOMBO MD: Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology (1998) 197(2):162-166.
39. GUPTA AK, RYDER JE: How to improve cure rates for the management of onychomycosis. Dermatol. Clin. (2003) 21(3):499-505.